The improvement in glycemic control and reduction in body weight with these compounds offers benefits to patients with T2D, with liraglutide (3.0 mg) also providing a treatment option for those with obesity and semaglutide under investigation for this indication
Prior authorization criteria for retatrutide will likely mirror Wegovy's: documented obesity with BMI 30 or BMI 27 with one weight-related comorbidity, and evidence of prior lifestyle modification
Chen: "Now that weve reviewed the therapy, its administration, and follow-up plan, do you feel ready to explore this option?" Monica: "Yes, lets try it
Compared patterns of antithrombin III, protein C, and protein S deficiencies
Glutathione crosses the blood-brain barrier in its liposomal form, where it protects neurons from free radical accumulation and supports mitochondrial function
Retrieved from Wolfe, M